Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study

Overview of attention for article published in Journal of Pain Research, December 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,018 followers.

RT @migrainelyfe: Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Scor | JPR https://t.co/7AM7jAhJiZ #chronicillness #Lyf…

Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Scor | JPR https://t.co/7AM7jAhJiZ #chronicillness #Lyfebulb #digtalhealth

☏ Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese ... #News https://t.co/q5KrhWNSqO